EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Radiological Intervention in Budd–Chiari Syndrome: Clinical Outcomes From a Single‐Center Study

Tai Ermongkonchai iD, Alysia Bastas iD, Katrina Tan iD, Adam Testro

International Journal of Hepatology · 2026-01 · 2026 (1)

DOI: 10.1155/ijh/2141081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hepatology, online erschienen am 12.08.2026. Verfasst von Tai Ermongkonchai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplant Unit Victoria, Austin Health, Heidelberg, Victoria, Australia, austin.org.au. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims Budd–Chiari Syndrome (BCS) is a vascular disease of the liver characterized by venous outflow obstruction most often due to a myeloproliferative neoplasm (MPN). Restoration of hepatic venous outflow and long‐term anticoagulation remain the mainstay of treatment. We examined our experiences and treatment outcomes of BCS, including comprehensive testing for underlying MPN.

Methods

A retrospective study was conducted to assess overall and transplant‐free survival in patients with primary BCS. All cases of primary BCS that presented to our institution over the past 3 decades were included. Details relating to their hematological work‐up and radiological interventions were recorded, as well as their longer term outcomes, including the need for liver transplantation.

Results

Forty‐three primary BCS patients were identified over a 28‐year period, with a median follow‐up time of 134 months. MPN was detected in 25 (62.5%) of cases who had comprehensive testing. All patients received primary anticoagulation. Seventeen (39.5%) patients underwent primary transjugular intrahepatic portosystemic shunt (TIPS). Twenty (46.5%) received anticoagulation alone as primary therapy, of whom 14 (70%) failed therapy and ultimately needed a rescue TIPS. Four (9.3%) patients underwent liver transplantation. Overall survival was 100% and 92.9% at 1 and 5 years, respectively, with transplant‐free survival of 97.7% and 88.1% at 1 and 5 years, respectively.

Conclusion

MPN (particularly JAK2V617F‐positive) is an important underlying cause of primary BCS. Anticoagulation alone without radiological intervention can lead to disease progression. In this single‐center cohort, early TIPS for rapid hepatic decompression appeared safe and was associated with excellent long‐term outcomes.

Schlagwörter

Stichwörter der Autor:innen

Budd–Chiari syndromeliver transplantmyeloproliferative disordertransjugular intrahepatic portosystemic shunt

Autor:innen und Institutionen

  • Liver Transplant Unit Victoria, Austin Health, Heidelberg, Victoria, Australia, austin.org.au.
  • Australian Centre for Transplantation Excellence and Research, Heidelberg, Victoria, Australia.
  • Department of Surgery (Austin Precinct), The University of Melbourne, Melbourne, Australia, unimelb.edu.au.

ORCID-Profile: Tai Ermongkonchai, Alysia Bastas, Katrina Tan

Zitieren

APA

Ermongkonchai, T., Bastas, A., Tan, K., & Testro, A. (2026). Early Radiological Intervention in Budd–Chiari Syndrome: Clinical Outcomes From a Single‐Center Study. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/2141081

Vancouver

Ermongkonchai T, Bastas A, Tan K, Testro A. Early Radiological Intervention in Budd–Chiari Syndrome: Clinical Outcomes From a Single‐Center Study. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/2141081

BibTeX
@article{Ermongkonchai2026,
  author = {Ermongkonchai, Tai and Bastas, Alysia and Tan, Katrina and Testro, Adam},
  title = {Early Radiological Intervention in Budd–Chiari Syndrome: Clinical Outcomes From a Single‐Center Study},
  journal = {International Journal of Hepatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijh/2141081}
}
Kostenlos starten →